Showing 20 of 43 recruiting trials for “graft-versus-host-disease”
Comparing the Therapeutic Effects of Using Ruxolitinib and Steroids Concurrently to Steroids Alone as Initial Treatment In Patients Diagnosed With Chronic Graft-versus-host Disease at a Grade of Moderate or Higher Severity
Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
Ibrutinib for the Prevention of Chronic Graft-Versus-Host Disease in Patients Undergoing Donor Stem Cell Transplant
A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
A Study to Evaluate the Safety and Efficacy of Axatilimab in Combination With Ruxolitinib in Participants With Newly Diagnosed Chronic Graft-Versus-Host Disease
Dose-Escalation Trial of Mesenchymal Stromal Cells in Patients With Medical Xerostomia
Tissue Immune Landscape of Graft Versus Host Disease After Allogeneic Stem Cell Transplantation (TIL-GVHD)
Ruxolitinib With and Without CTLA-4 Ig Abatacept for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
👨⚕️ Ramzi Abboud, M.D., Washington University School of Medicine📍 1 site📅 Started May 2024View details ↗
A Clinical Trial of TQ05105 Tablets in the Treatment of Chronic Graft-versus-host Disease
Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-Disease
Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
👨⚕️ Stephanie Lee, MD, MPH, Fred Hutch/University of Washington Cancer Consortium📍 4 sites📅 Started Dec 2023View details ↗
Leflunomide in Combination With Steroids for the Treatment of Acute Graft-versus-Host Disease After Donor Stem Cell Transplant for Hematologic Malignancies
RecruitingNCT05718791 ↗
CXCL9 and EASIX for Prediction of Acute Graft Versus Host Disease
Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
Impact of Exercise on the Complications of Corticosteroids in Patients With GVHD: the RESTART Trial
👨⚕️ Christina Dieli-Conwright, Dana-Farber Cancer Institute📍 2 sites📅 Started Apr 2022View details ↗
Addition of Cord Blood Tissue-Derived Mesenchymal Stromal Cells to Ruxolitinib for the Treatment of Steroid-Refractory Acute Graft Versus Host Disease
RecruitingNCT04700657 ↗
The Prevalence of Hypoesthesia Related Keratitis in Ocular Graft Vs. Host Disease (GVHD) Patients
RecruitingNCT04660487 ↗
Relationship Between "FODMAPs" and "GVHD"
A Feasibility Study Using CLINIMACS® for Alpha/Beta T-Cell Depletion in Stem Cell Transplant
👨⚕️ Christopher C Dvorak, MD, Professor of Clinical Pediatrics📍 1 site📅 Started Dec 2019View details ↗
RecruitingNCT03602599 ↗
Chronic Graft-versus-Host Disease in the Oral Cavity of Patients Following Allogeneic Hematopoietic Stem Cell Transplant and Including Healthy Controls
👨⚕️ Jacqueline W Mays, D.D.S., National Institute of Dental and Craniofacial Research (NIDCR)📍 1 site📅 Started Nov 2018View details ↗
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →